ARDX
Companies
NASDAQ
Ardelyx Inc.
Health Care
$3.61
-$1.46 (-28.80%)
Price Chart
Overview
About ARDX
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Market Cap
$1.5B
Volume
20.1M
Avg. Volume
15.0M
P/E Ratio
-62.42857
Dividend Yield
0.00%
Employees
233.0
Company Information
Latest News for ARDX
Risk & Correlation Analysis
Market Correlation
1.52
High Correlation
Volatility
High (0.78)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ARDX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.5B
Volume20.1M
P/E Ratio-62.43
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 20, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025